NCT03066635View on ClinicalTrials.gov

Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 18, 2017

Primary Completion Date

September 13, 2019

Study Completion Date

September 13, 2019

Conditions
Cluster Headache
Interventions
DRUG

Botulinum Toxin Type A 25 IU

injection with 25 IU botulinum toxin towards the otic ganglion (symptomatic side) using image-guided navigation and the MultiGuide device

DRUG

Botulinum Toxin Type A 12.5 IU

injection with 12.5 IU botulinum toxin towards the otic ganglion (symptomatic side) using image-guided navigation and the MultiGuide device

Trial Locations (1)

Unknown

Department of Neuroscience, Norwegian University of Science and Technology, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT03066635 - Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues | Biotech Hunter | Biotech Hunter